Ticagrelor is a P2Y12 platelet inhibitor prescribed to minimize the risk of myocardial infarction, strokes, and cardiovascular deaths in patients with coronary artery disease. This product is the DrugMonitor™ Anti-Ticagrelor Antibody (VS-0125-YC1885), specifically designed as an anti-drug antibody (ADA) that targets Ticagrelor. The ADA was raised in Balb/c mice immunized with Ticagrelor conjugated to BSA and is suitable for use in ELISA and lateral flow assays. As a drug-based antibody, it also serves as an exemplary tool for therapeutic drug monitoring, facilitating the determination of Ticagrelor drug concentrations in various samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-723 | Human Anti-Ticagrelor Recombinant Antibody (PABL-723) | WB, FuncS | Human IgG |
HPAB-0557-FY | Human Anti-Ticagrelor Recombinant Antibody (HPAB-0557-FY) | Inhib | Human IgG |
HPAB-0558-FY | Human Anti-Ticagrelor Recombinant Antibody (HPAB-0558-FY) | Inhib | Human IgG |
HPAB-2078-FY | Human Anti-TICAGRELOR Recombinant Antibody (clone Fab72) | Inhib, ELISA | Human IgG |
There are currently no Customer reviews or questions for VS-0125-YC1885. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.